Key points are not available for this paper at this time.
Supplemental Figure S9 shows the in vitro anti-tumor effect and tolerability of D3S-001 as monotherapy or in combination with D3S-002 on sotorasib-resistant models.
Zhang et al. (2024) studied this question.